SAFETY AND IMMUNOGENICITY OF WITH NOVEL MALARIA VACCINE CANDIDATE, R21 ADJUVANTED WITH MATRIX M1
Venkatraman N., Sridhar S., Bowyer G., Angell-Manning P., Powlson J., Bliss C., Glenn G., Poulton I., Moyle S., Berrie E., Green N., Mukhopadhyay E., Lawrie A., Roberts R., Lewis DJ., Ewer K., Hill AV.